A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

• 

• 
  • The Journal
  • Editor-In-Chief
  • Editorial Calendar
  • Submissions
  • Advertising
  • Permissions & Reprints
  • Privacy Policy

• 
  • Subscribe
  • Renew
  • Prices
  • Free Sample

• 
  • View Shopping Cart
  • Back Issues
  • Articles
  • Library Archives
  • Compounding Theme Archives
  • Other Products

• 
  • Supplemental Content and Errata
  • Training and Education
  • IJPC-PCAB SOP Matrix
  • USP GAP Analysis
  • Compounders' Network List
  • Patient Information
  • Videos
  • Compounders' Resource Directory

• 

• 

Basics of Compounding: Basics of Compounding with Potency Designated Ingredients

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2011 - Volume 15, Number 1
View All Articles in Issue

Abstract:  Pharmacists involved in compounding must consider a number of factors when determining the actual quantity of an active ingredient to use for a compounded prescription. Many drug substances do not consist of 100% drug or chemical, and adjustments must be made to obtain the required amount of active drug (active pharmaceutical ingredient). This article covers the topic of compounding with “potency-designated” drugs.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, bulk substance potency, biologic agents, biological agents, active pharmaceutical ingredients, drug potency designations, drug activity

Related Categories: SUPPORT

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy
Wetting and/or Solubilizing Agents, Featured Excipient:	Allen Loyd V Jr	Jul/Aug 2001	310-312	Buy
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients	Allen Loyd V Jr	Jan/Feb 2011	56-61	Buy
Compounding for the Effects of Weapons of Mass Destruction	Sammarco Domenic A	Jan/Feb 2003	10-15	View Sample
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh	Allen Loyd V Jr	Nov/Dec 2003	449-450	Buy
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA	Cabaleiro Joe	Sep/Oct 2021	358-362	Buy
Basics of Sterile Compounding: Excipients Used in Injections	Akers Michael J	Jul/Aug 2017	301-308	Buy
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents	Allen Loyd V Jr, McKenzie Robert, Ainsworth Ron, Kastango Eric S, Kaestner Rick, Rebelo Andre, Burnside Paul, Schultz Gerald	Jul/Aug 2010	284-300	Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Miller David G	Jul/Aug 2015	303-305	Buy
Compounding with Biotechnology Products, Part 1: General Considerations	Allen Loyd V Jr	Sep/Oct 2022	385-395	Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Allen Loyd V Jr	Jul/Aug 2016	351	View Sample